Overall, plasma NfL levels were markedly lower at 56 days after stroke compared to the 3 day timepoint in all groups, and plasma NfL levels were no longer correlated with stroke size at this chronic timepoint (Spearman rho = 0.1289; p = 0.3220). The gene discussed is NEFL; the disease is stroke disorder.